[Therapeutic options for perioperatively acquired platelet dysfunctions]

Anaesthesist. 2009 Sep;58(9):931-2, 934-6, 938-40. doi: 10.1007/s00101-009-1599-8.
[Article in German]

Abstract

Increased intra-operative and postoperative blood loss might be caused by acquired platelet function disorders. In particular because conventional coagulation analyses and platelet count fail to detect impaired platelet function, implementation of bedside-tests for platelet function in the peri-operative period is desirable according to the results of retrospective studies. Following adequate adjustment of basic conditions of haemostasis (e.g. temperature, pH, Ca2+-concentration, haematocrit) a pharmacological approach with desmopressin (1-desamino-8-d-arginine vasopressin; DDAVP) or tranexamic acid potentially represents a low cost alternative to platelet transfusions with minor side effects.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antifibrinolytic Agents / therapeutic use
  • Blood Loss, Surgical / physiopathology
  • Blood Platelet Disorders / drug therapy
  • Blood Platelet Disorders / etiology
  • Blood Platelet Disorders / therapy*
  • Deamino Arginine Vasopressin / therapeutic use
  • Factor VIIa / therapeutic use
  • Fibrinogen / therapeutic use
  • Hemostasis
  • Humans
  • Monitoring, Intraoperative
  • Perioperative Care
  • Platelet Function Tests
  • Platelet Transfusion
  • Recombinant Proteins / therapeutic use
  • Tranexamic Acid / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Recombinant Proteins
  • Tranexamic Acid
  • Fibrinogen
  • Factor VIIa
  • Deamino Arginine Vasopressin